Scancell has announced that it has raised £3.877m (gross) through the issue of 77.6m new shares to Vulpes Life Sciences Fund at a price of 5p per share. The new investment results in Vulpes holding 16.67% of the enlarged share capital, overtaking Calculus Capital as the largest shareholder.
13 Jun 2019
Vulpes investment brings £3.88m in new funds
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Vulpes investment brings £3.88m in new funds
Scancell Holdings Plc (SCLP:LON) | 9.6 0 0.0% | Mkt Cap: 89.1m
- Published:
13 Jun 2019 -
Author:
Mick Cooper PhD -
Pages:
2
Scancell has announced that it has raised £3.877m (gross) through the issue of 77.6m new shares to Vulpes Life Sciences Fund at a price of 5p per share. The new investment results in Vulpes holding 16.67% of the enlarged share capital, overtaking Calculus Capital as the largest shareholder.